Prostaglandin F Synthase (human recombinant)
Cayman Chemical Item Number 10007940
AKR1C3; PGFS
Description
Source:
recombinant C-terminal hexahistidine-tagged protein expressed in E. coli
·
Mr:
~37 kDa
·
Protein concentration:
0.8 mg/ml
·
Human prostaglandin F synthase (PGFS) is a ~37 kDa monomeric protein with high sequence similarity to aldo-keto reductase family members.1 It exhibits two related primary activities, catalyzing the isomerization of PGH2 to PGF2α (PGH2 9,11-endoperoxide reductase activity), as well as the formation of 11β-PGF2α from PGD2 (PGD2 11-ketoreductase activity) in the presence of NADPH. The enzyme also exhibits reductase activities toward carbonyl compounds such at nitroacetophenone, nitrobenzaldehyde, and 9,10-phenanthrene quinine (PQ).2 Cayman’s human recombinant PGFS has been expressed and purified from an E.coli overexpression system. Enzyme activity was determined by monitoring the change in absorbance at 340 nm using PGD2 as the substrate and NADPH as the cofactor (PGD2 11-ketoreductase activity).
1
Urade, Y., Watanabe, K., and Hayaishi, O. Prostaglandin D, E, and F synthases. J Lipid Mediat Cell Signal 12 257-273 (1995).
2
Suzuki, T., Fuji, Y., Miyano, M., et al. cDNA cloning, expression, and mutagenesis study of liver-type prostaglandin F synthase. J Biol Chem 274 241-248 (1999).
| Synonyms |
|
| Formulation |
A solution in 100 mM sodium phosphate, pH 7.2, containing 20% glycerol, 100 mM sodium chloride, and 1 mM EDTA |
| Purity |
≥90% |
| Stability |
6 months |
| Storage |
-80°C |
| Shipping |
Dry ice
in continental US; may vary elsewhere
|
Background Reading
Urade, Y., Watanabe, K., and Hayaishi, O. Prostaglandin D, E, and F synthases. J Lipid Mediat Cell Signal 12 257-273 (1995).
Suzuki, T., Fuji, Y., Miyano, M., et al. cDNA cloning, expression, and mutagenesis study of liver-type prostaglandin F synthase. J Biol Chem 274 241-248 (1999).
Komoto, J., Yamada, T., Watanabe, K., et al. Crystal structure of human prostaglandin F synthase (AKR1C3). Biochemistry 43 2188-2198 (2004).
Lovering, A.L., Ride, J.P., Bunce, C.M., et al. Crystal structures of prostaglandin D2 11-ketoreductase (AKR1C3) in complex with the nonsteroidal anti-inflammatory drugs flufenamic acid and indomethacin. Cancer Res 64 1802-1810 (2004).
Watanabe, K., Yoshida, R., Shimizu, T., et al. Enzymatic formation of prostaglandin F2α from prostaglandin H2 and D2. Purification and properties of prostaglandin F synthetase from bovine lung. J Biol Chem 260(11) 7035-7041 (1985).
Komoto, J., Yamada, T., Watanabe, K., et al. Prostaglandin F2α formation from prostaglandin H2 by prostaglandin F synthase (PGFS): Crystal structure of PGFS containing bimatoprost. Biochemistry 45(7) 1987-1996 (2006).
Show all 6
Hide all but first 3
|
Pricing updated 2012-02-12.
Prices are subject to change without notice.
To ask for assistance with one of our products please contact a Technical Support Scientist.
Warning This product is not for human or veterinary use.
Show all 5
Hide all but first 3
Downloads
Batch-specific Information
Login
to access batch-specific information
|